Catalyst Wire Dossier Catalyst Wire Dossier

Potassium citrate extended-release tablets

potassium citrate extended-release tablets · Dawnrays Pharmaceutical (Holdings) Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Potassium citrate extended-release tablets, covering 2018-02-01 to 2018-02-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence [Phase 4]

See pricing